• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Antares Pharma Inc

+ Add to Watchlist


2.218 EUR 0.082 3.84%

As of 09:32:19 ET on 12/23/2014.

Snapshot for Antares Pharma Inc (MJC)

Open: 2.218 Day's Range: 2.218 - 2.218 Volume: 0
Previous Close: 2.136 52wk Range: 1.398 - 3.690 1-Yr Rtn: -27.59%

Stock Chart for MJC

No chart data available.
  • MJC:GR 2.218
  • 1D
  • 1M
  • 1Y
Interactive MJC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MJC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.2350
Est. PEG Ratio -
Market Cap (M EUR) 292.08
Shares Outstanding (M) 131.68
30 Day Average Volume 79
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MJC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MJC

Antares Pharma, Inc. develops pharmaceutical delivery systems, including needle-free and mini-needle injector systems and transdermal gel technologies. The Company distributes its needle-free injector systems in various countries. Antares also conducts research and development with transdermal gel products and has several products in clinical evaluation with partners.

Eamonn P HobbsPresident/CEORobert F Apple "Bob"Exec VP/COO
James E FickenscherSenior VP/CFOJennifer Evans StaceySenior VP/Secy/Gen Counsel:HR
More Company Profile & Key Executives for MJC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
  • MJC News

  • Industry News

No stories found
No stories found
Sponsored Links
sec ||= nil